@article{article, title = {{SunRISe-3: TAR-200 plus cetrelimab or TAR-200 versus intravesical Bacillus Calmette鈥揋u茅rin in patients with BCG-naive high-risk non鈥搈uscle-invasive bladder cancer}}, publisher = {{Elsevier BV}}, url = {{http://dx.doi.org/10.1016/s0302-2838(24)01168-0 }}, year = {{2024}}, month = {{3}}, author = {{Catto JWF and Necchi A and Powles T and Guerrero-Ramos F and Simone G and Shore N and Salinas JS and Merseburger AS and Roumiguie M and Hiroshi K and Morris DM et al}}, doi = {{10.1016/s0302-2838(24)01168-0}}, volume = {{85}}, journal = {{European Urology}}, pages = {{S1505-S1505}}, note = {{Accessed on 2025/07/28}}}